Skip to content

Study of CI-AKI Diagnostic Classification and Prognostic Prediction Model Based on Comprehensive Characteristics of Renal Parenchyma and Function Damages

Study of CI-AKI Diagnostic Classification and Prognostic Prediction Model Based on Comprehensive Characteristics of Renal Parenchyma and Function Damages

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018031
Enrollment
Unknown
Registered
2018-08-27
Start date
2018-10-30
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-induced acute kidney injury

Interventions

Gold Standard:CI-AKI is defined as an increase in SCr concentration of at least 0.3mg/dl or 50% from baseline within 72 hours after contrast media exposure
or an increase in sCyC of at least 15% within 48 hours after
or an increase in NAGL of at least 179ng/ml within 6 hours after.
is&#32
6±1&#32
after&#32
angiography.

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age with acute myocardial infarction who are scheduled to undergo coronary angiography are prospectively recruited.

Exclusion criteria

Exclusion criteria: 1) pregnancy or lactation; 2) end-stage renal disease on maintenance dialysis; 3) Killip III or IV; 4) recent exposure to contrast media or concomitant use of nephrotoxic agents (within 1 week before procedure); 5) enrollment in other clinical trials.

Design outcomes

Primary

MeasureTime frame
microRNA;

Secondary

MeasureTime frame
Composites of cardiovascular and renal adverse events;

Countries

China

Contacts

Public ContactLINGHONG SHEN

Shanghai Chest Hospital

drshenlinghong@126.com+86 13916495713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026